• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

勃起功能障碍的评估与治疗。

Evaluation and treatment of erectile dysfunction.

机构信息

Laboratory of Experimental Urology, Department of Urology, University Hospitals Leuven, Herestraat 49, Leuven 3000, Belgium.

出版信息

Med Clin North Am. 2011 Jan;95(1):201-12. doi: 10.1016/j.mcna.2010.08.016.

DOI:10.1016/j.mcna.2010.08.016
PMID:21095423
Abstract

Erectile dysfunction (ED) is a prevalent and important disease that has been associated with various comorbidities. The evaluation of patients with ED should include a general health assessment followed by a discussion of reversible factors and lifestyle changes that might help preserve erectile capacity. Numerous effective treatment options are currently available. A frank discussion about use and side effects of these therapies is required to optimize success. Although oral pharmacologic treatments can be initiated and monitored by the primary care physician, patients who do not experience response to these treatments may be best served by referral to a sexual medicine specialist for further assessment and consideration of other treatment options. This article discusses the physiology and pathophysiology of erectile function in men, how the primary care physician may address the clinical problem of ED in practice, and when specialty referral is indicated.

摘要

勃起功能障碍(ED)是一种普遍且重要的疾病,与多种合并症相关。ED 患者的评估应包括一般健康评估,然后讨论可能有助于保持勃起能力的可逆因素和生活方式改变。目前有许多有效的治疗选择。需要坦诚地讨论这些疗法的使用和副作用,以优化治疗效果。虽然初级保健医生可以启动和监测口服药物治疗,但对这些治疗没有反应的患者最好由性医学专家进一步评估,并考虑其他治疗选择。本文讨论了男性勃起功能的生理学和病理生理学,初级保健医生如何在实践中解决 ED 的临床问题,以及何时需要专科转诊。

相似文献

1
Evaluation and treatment of erectile dysfunction.勃起功能障碍的评估与治疗。
Med Clin North Am. 2011 Jan;95(1):201-12. doi: 10.1016/j.mcna.2010.08.016.
2
Evaluation and treatment of erectile dysfunction in the aging male: a mini-review.老年男性勃起功能障碍的评估和治疗:小型综述。
Gerontology. 2012;58(1):3-14. doi: 10.1159/000329598. Epub 2011 Sep 7.
3
Core document on erectile dysfunction: key aspects in the care of a patient with erectile dysfunction.勃起功能障碍核心文件:勃起功能障碍患者护理的关键要点
Int J Impot Res. 2004 Oct;16 Suppl 2:S26-39. doi: 10.1038/sj.ijir.3901240.
4
Erectile Dysfunction.勃起功能障碍
Prim Care. 2019 Jun;46(2):249-255. doi: 10.1016/j.pop.2019.02.006. Epub 2019 Apr 1.
5
The management of erectile dysfunction in the community.社区中勃起功能障碍的管理
Int J Impot Res. 2001 Aug;13 Suppl 3:S45-51. doi: 10.1038/sj.ijir.3900723.
6
Recent advances in the understanding and management of erectile dysfunction.勃起功能障碍的认识与治疗的最新进展
F1000Res. 2019 Jan 25;8. doi: 10.12688/f1000research.16576.1. eCollection 2019.
7
Erectile dysfunction. A guide to diagnosis and management.勃起功能障碍:诊断与管理指南
Aust Fam Physician. 2003 Jun;32(6):414-20.
8
Performance and safety of treatment options for erectile dysfunction in patients with spinal cord injury: A review of the literature.脊髓损伤患者勃起功能障碍治疗选择的疗效和安全性:文献综述。
Andrology. 2020 Nov;8(6):1660-1673. doi: 10.1111/andr.12878. Epub 2020 Aug 19.
9
The 2018 Revision to the Process of Care Model for Management of Erectile Dysfunction.2018 年版勃起功能障碍管理护理流程模式修订版。
J Sex Med. 2018 Oct;15(10):1434-1445. doi: 10.1016/j.jsxm.2018.05.021. Epub 2018 Jul 26.
10
Management of erectile dysfunction in general practice.全科医疗中勃起功能障碍的管理
J Sex Med. 2009 Apr;6(4):1127-1134. doi: 10.1111/j.1743-6109.2008.01093.x. Epub 2008 Dec 5.

引用本文的文献

1
The sexual functions of male patients suffering from affective disorders.患有情感障碍的男性患者的性功能。
Postep Psychiatr Neurol. 2024 Jun;33(2):54-58. doi: 10.5114/ppn.2024.141052. Epub 2024 Jul 10.
2
Carotid artery intima media thickness can predict the response to phosphodiesterase 5 inhibitors in patients with moderate erectile dysfunction.颈动脉内膜中层厚度可预测中度勃起功能障碍患者对磷酸二酯酶5抑制剂的反应。
Sex Med. 2023 Jul 31;11(3):qfad042. doi: 10.1093/sexmed/qfad042. eCollection 2023 Jun.
3
Male Sexual Dysfunction.
男性性功能障碍
Health Psychol Res. 2022 Aug 20;10(3):37533. doi: 10.52965/001c.37533. eCollection 2022.
4
Urine-Derived Stem Cells Versus Their Lysate in Ameliorating Erectile Dysfunction in a Rat Model of Type 2 Diabetes.在2型糖尿病大鼠模型中,尿液来源的干细胞与其裂解物在改善勃起功能障碍方面的比较
Front Physiol. 2022 May 10;13:854949. doi: 10.3389/fphys.2022.854949. eCollection 2022.
5
Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case Series.腔内注射依库珠单抗(Xeomin)100U 作为标准药物治疗难治性勃起功能障碍的附加治疗的有效性和安全性:病例系列。
Toxins (Basel). 2022 Apr 16;14(4):286. doi: 10.3390/toxins14040286.
6
Practical Approaches to Treat ED in PDE5i Nonresponders.治疗对5型磷酸二酯酶抑制剂无反应的勃起功能障碍的实用方法。
Aging Dis. 2020 Oct 1;11(5):1202-1218. doi: 10.14336/AD.2019.1028. eCollection 2020 Oct.
7
Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis.口服磷酸二酯酶 5 抑制剂治疗勃起功能障碍的疗效和安全性:一项网状 meta 分析和多准则决策分析。
World J Urol. 2021 Mar;39(3):953-962. doi: 10.1007/s00345-020-03233-9. Epub 2020 May 9.
8
Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails.5型磷酸二酯酶抑制剂治疗失败时勃起功能障碍的非侵入性管理方案
Drugs Aging. 2018 Mar;35(3):175-187. doi: 10.1007/s40266-018-0528-4.
9
Penile alterations at early stage of type 1 diabetes in rats.大鼠1型糖尿病早期的阴茎改变
Int Braz J Urol. 2017 Jul-Aug;43(4):753-761. doi: 10.1590/S1677-5538.IBJU.2016.0454.
10
Recombinant PAI-1 therapy restores myoendothelial junctions and erectile function in PAI-1-deficient mice.重组纤溶酶原激活物抑制剂-1疗法可恢复纤溶酶原激活物抑制剂-1缺陷小鼠的肌内皮连接和勃起功能。
Andrologia. 2015 Dec;47(10):1147-52. doi: 10.1111/and.12395. Epub 2014 Dec 29.